Neovasc Inc. Operating Income Growth

Operating Income Growth of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Income Growth for the quarter ending March 31, 2022 was 34.95% (a -21.03% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Income Growth decreased by -797.6%
  • Annual Operating Income Growth for 2021 was 11.54% (a -167.72% decrease from previous year)
  • Annual Operating Income Growth for 2020 was -17.04% (a -333.74% decrease from previous year)
  • Annual Operating Income Growth for 2019 was 7.29% (a -1000.0% decrease from previous year)
  • Twelve month Operating Income Growth ending March 31, 2022 was 27.84% (a 141.25% increase compared to previous quarter)
  • Twelve month trailing Operating Income Growth decreased by -244.55% year-over-year
Trailing Operating Income Growth for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
27.84% 11.54% 1.07% -19.26%
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income Growth of Neovasc Inc.

Most recent Operating Income Growthof NVCN including historical data for past 10 years.

Interactive Chart of Operating Income Growth of Neovasc Inc.

Neovasc Inc. Operating Income Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 34.95%
2021 44.26% 33.87% -5.01% -42.15% 11.54%
2020 4.05% -45.41% -30.53% -4.51% -17.04%
2019 6.63% 27.54% -10.49% -5.3% 7.29%
2018 16.03% -65.66% 4.64% 16.81% -0.81%
2017 -81.47% 23.21% 51.55% 17.84% 12.69%
2016 16.47% 12.53% -90.28% -83.51% -28.04%
2015 -13.71% -97.99% -15.49% -1308.8% -66.52%
2014 -217.29% -226.38% -334.78% 80.98% -150.29%
2013 -122.63% -12.3% 8.79% -56.05% -40.24%
2012 -155.66% 10.95% -9.63% 35.92% -26.8%
2011 279.66% 21.14%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.